Evidence map›Paper›PMID 24551247›Full record

ArticlePloS one2014

A type VI secretion system is involved in Pseudomonas fluorescens bacterial competition.

Victorien Decoin, Corinne Barbey, Dorian Bergeau, Xavier Latour, Marc G J Feuilloley, Nicole Orange, Annabelle Merieau

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. The Anti-Listeria Activity ofPathogens (Basel, Switzerland) · 2023
    Article
  12. Review
  13. Frontiers in microbiology · 2023
    Article
  14. Review
  15. Characterization ofJournal of microbiology and biotechnology · 2022
    Article
  16. Genome sequence ofHeliyon · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Victorien DecoinLMSM, Laboratoire de Microbiologie Signaux et Microenvironnement, Normandie Université, EA 4312, Université de Rouen, IUT d'Evreux, Evreux, France.
Corinne BarbeyLMSM, Laboratoire de Microbiologie Signaux et Microenvironnement, Normandie Université, EA 4312, Université de Rouen, IUT d'Evreux, Evreux, France.
Dorian BergeauLMSM, Laboratoire de Microbiologie Signaux et Microenvironnement, Normandie Université, EA 4312, Université de Rouen, IUT d'Evreux, Evreux, France.
Xavier LatourLMSM, Laboratoire de Microbiologie Signaux et Microenvironnement, Normandie Université, EA 4312, Université de Rouen, IUT d'Evreux, Evreux, France.
Marc G J FeuilloleyLMSM, Laboratoire de Microbiologie Signaux et Microenvironnement, Normandie Université, EA 4312, Université de Rouen, IUT d'Evreux, Evreux, France.
Nicole OrangeLMSM, Laboratoire de Microbiologie Signaux et Microenvironnement, Normandie Université, EA 4312, Université de Rouen, IUT d'Evreux, Evreux, France.
Annabelle MerieauLMSM, Laboratoire de Microbiologie Signaux et Microenvironnement, Normandie Université, EA 4312, Université de Rouen, IUT d'Evreux, Evreux, France.
Université de Rouen Normandie · FRNormandie Université · FR

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Protein secretion systems are crucial mediators of bacterial interactions with other organisms. Among them, the type VI secretion system (T6SS) is widespread in Gram-negative bacteria and appears to inject toxins into competitor bacteria and/or eukaryotic cells. Major human pathogens, such as Vibrio cholerae, Burkholderia and Pseudomonas aeruginosa, express T6SSs. Bacteria prevent self-intoxication by their own T6SS toxins by producing immunity proteins, which interact with the cognate toxins. We describe here an environmental P. fluorescens strain, MFE01, displaying an uncommon oversecretion of Hcp (hemolysin-coregulated protein) and VgrG (valine-glycine repeat protein G) into the culture medium. These proteins are characteristic components of a functional T6SS. The aim of this study was to attribute a role to this energy-consuming overexpression of the T6SS. The genome of MFE01 contains at least two hcp genes (hcp1 and hcp2), suggesting that there may be two putative T6SS clusters. Phenotypic studies have shown that MFE01 is avirulent against various eukaryotic cell models (amebas, plant or animal cell models), but has antibacterial activity against a wide range of competitor bacteria, including rhizobacteria and clinical bacteria. Depending on the prey cell, mutagenesis of the hcp2 gene in MFE01 abolishes or reduces this antibacterial killing activity. Moreover, the introduction of T6SS immunity proteins from S. marcescens, which is not killed by MFE01, protects E. coli against MFE01 killing. These findings suggest that the protein encoded by hcp2 is involved in the killing activity of MFE01 mediated by effectors of the T6SS targeting the peptidoglycan of Gram-negative bacteria. Our results indicate that MFE01 can protect potato tubers against Pectobacterium atrosepticum, which causes tuber soft rot. Pseudomonas fluorescens is often described as a major PGPR (plant growth-promoting rhizobacterium), and our results suggest that there may be a connection between the T6SS and the PGPR properties of this bacterium.

Indexed as

Bacterial Secretion SystemsMicrobial InteractionsAnimalsAnti-Bacterial AgentsBacterial ProteinsEscherichia coliGenes, BacterialHumansImmunityMicrobial ViabilityMutationPectobacteriumPlasmidsPseudomonas fluorescensSerratia marcescensVirulenceAnti-Bacterial AgentsBacterial ProteinsBacterial Secretion Systems

Identifiers

PMID24551247
PMCPMC3925238
OpenAlexW2039306526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.